Clinical benefit of gluten-free diet in screen-detected older celiac disease patients

Department of Neurology, Päijät-Häme Central Hospital, Lahti, Finland.
BMC Gastroenterology (Impact Factor: 2.37). 12/2011; 11(1):136. DOI: 10.1186/1471-230X-11-136
Source: PubMed


The utility of serologic screening for celiac disease is still debatable. Evidence suggests that the disorder remains undetected even in the older population. It remains obscure whether screening makes good or harm in subjects with long-standing gluten ingestion. We evaluated whether older subjects benefit from active detection and subsequent gluten free dietary treatment of celiac disease.
Thirty-five biopsy-proven patients aged over 50 years had been detected by serologic mass screening. We examined the disease history, dietary compliance, symptoms, quality of life and bone mineral density at baseline and 1-2 years after the commencement of a gluten-free diet. Symptoms were evaluated by gastrointestinal symptom rating scale and quality of life by psychological general well-being questionnaires. Small bowel biopsy, serology, laboratory parameters assessing malabsorption, and bone mineral density were investigated.
Dietary compliance was good. The patients had initially low mean serum ferritin values indicating subclinical iron deficiency, which was restored by a gluten-free diet. Vitamin B12, vitamin D and erythrocyte folic acid levels increased significantly on diet. Celiac patients had a history of low-energy fractures more often than the background population, and the diet had a beneficial effect on bone mineral density. Alleviation in gastrointestinal symptoms was observed, even though the patients reported no or only subtle symptoms at diagnosis. Quality of life remained unchanged. Of all the cases, two thirds would have been diagnosed even without screening if the family history, fractures or concomitant autoimmune diseases had been taken carefully into account.
Screen-detected patients benefited from a gluten-free diet. We encourage a high index of suspicion and active case-finding in celiac disease as an alternative to mass screening in older patients.

Download full-text


Available from: Raisa Valve,
32 Reads
  • Source
    • "2005 USA 24 CD 20 control BMD significantly reduced in treated vs . control Pazianas et al . 2005 [ 95 ] 2006 Norway 118 CD BMD significantly reduced ( P < 0 . 001 ) at all sites Deressa et al . 2006 [ 96 ] 2009 Brazil 31 CD Low BMD in 9% Motta et al . 2009 [ 97 ] 2011 Finland 35 CD Low BMD in 62% Vilppula et al . 2011 [ 99 ] 2012 Italy 70 CD on GFD Low BMD in 74% ( among these : 24% osteoporosis ; 76% osteopenia ) Larussa et al . 2012 [ 80 ] In pediatric CD patients 2003 Brasil 30 CD ( 17 children ; 13 adolescents ) 23 control BMD of adolescents lower than control ; no differences in BMD of children vs . control Sdepanian et al . 2003 [ 84 ] 2003 Tur"
    [Show abstract] [Hide abstract]
    ABSTRACT: Low bone mineral density (BMD), osteopenia, and osteoporosis are frequent complications of celiac disease (CD). The etiology of pathologic bone alterations in CD is multifactorial; however, two main mechanisms are involved: intestinal malabsorption and chronic inflammation. A strict gluten-free diet (GFD) is thought to be the only effective treatment for CD; but treating bone complications related to CD remains complex. The objective of this review is to elucidate the bones problems related to CD and to increase awareness of osteoporosis development, considered as a sign of atypical CD presentation. Currently, a question of whether GFD alone is an effective treatment to correct the bone alterations in patients with CD is under debate. This review presents factors contributing to pathologic bone derangement, recent research on the epidemiology of low BMD, osteoporosis, and fractures, and the treatment of bone problems in patients with CD. The roles of calcium and transport mechanisms are additionally presented.
    Nutrition 01/2014; 30(1):16-24. DOI:10.1016/j.nut.2013.05.027 · 2.93 Impact Factor
  • Source
    • "Several studies evaluated bone status in celiac disease (CD), both at diagnosis and after gluten-free diet (GFD), and to date, it has been recognized that bone involvement may be a frequent finding during CD. Nevertheless, studies focusing on the prevalence of bone derangement in celiac patients are still inconclusive since both old and recent findings fall in a wide range ([3, 11], see Table 1). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Evidence indicates a well-established relationship between low bone mineral density (BMD) and celiac disease (CD), but data on the pathogenesis of bone derangement in this setting are still inconclusive. In patients with symptomatic CD, low BMD appears to be directly related to the intestinal malabsorption. Adherence to a strict gluten-free diet (GFD) will reverse the histological changes in the intestine and also the biochemical evidence of calcium malabsorption, resulting in rapid increase of BMD. Nevertheless, GFD improves BMD but does not normalize it in all patients, even after the recovery of intestinal mucosa. Other mechanisms of bone injury than calcium and vitamin D malabsorption are thought to be involved, such as proinflammatory cytokines, parathyroid function abnormalities, and misbalanced bone remodeling factors, most of all represented by the receptor activator of nuclear factor B/receptor activator of nuclear factor B-ligand/osteoprotegerin system. By means of dual-energy X-ray absorptiometry (DXA), it is now rapid and easy to obtain semiquantitative values of BMD. However, the question is still open about who and when submit to DXA evaluation in CD, in order to estimate risk of fractures. Furthermore, additional information on the role of nutritional supplements and alternative therapies is needed.
    Gastroenterology Research and Practice 04/2012; 2012(15):198025. DOI:10.1155/2012/198025 · 1.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article reviews issues related to identifying the appropriate patient to test for celiac disease, the performance characteristics of serologic testing, the role of gene testing for human leukocyte antigen DQ2 and DQ8 haplotypes, and issues related to the performance of small intestinal biopsy. The article concludes with a review of special diagnostic considerations in pediatric patients.
    Gastrointestinal endoscopy clinics of North America 10/2012; 22(4):661-77. DOI:10.1016/j.giec.2012.07.004
Show more